Inflammation and the Host Response to Injury (Burns)

This large-scale collaborative project provides the means to acquire the necessary new knowledge directly in humans. Knowledge will be acquired using diverse state-of-the-art genomic and proteomic technologies, a highly complex clinical, proteomic, and genomic database, as well as newly-developed, novel analytical tools to probe this complex dataset. Our analytical capabilities at the genomic and proteomic level are now rapidly evolving and our ability to link these genomic and proteomic data to pathways and functional modules will help us more closely link this cellular data to immunological processes and ultimately, to the phenotypic response (i.e., trajectory) in the injured host. As a result, potential interventions, whether through our Program or other funding mechanisms, can be more effectively designed.

Inclusion criteria

• Burn patients of all ages with 20% or greater of total body surface area burns that require surgical treatment
• Burn patients admitted to the burn unit within 96 hours (4 days) of burn injury

All patients meeting these criteria are entered into the epidemiologic database and assessed for specific exclusion criteria to establish whether serial blood draws are warranted.

Exclusion criteria

• Injury caused by chemical agent
• Deep injury caused by conduction of electrical current or charge
• Decision not to treat due to severity of injury
• Anoxic brain injury that is not expected to result in complete recovery
• Associated multiple injuries exclusive of burns (ISS >=25)
• Pre-morbid condition: Severe congestive heart failure (measured ejection fraction <20%)
• Pre-morbid condition: Malignancy currently under treatment
• Pre-morbid condition: Medical condition requiring systemic glucocorticoid treatment
• Pre-morbid condition: current systemic immunosuppression for organ transplant or chronic inflammatory condition